Primary Axillary Hyperhidrosis

DBCOND0060333Signs, Symptoms, and General PathologiesSkin and Subcutaneous Tissue Diseases

Primary Axillary Hyperhidrosis is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Primary Focal Hyperhidrosis, Axilla · Hyperhidrosis Primary Focal Axilla
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10L74.510SNOMED CT10677551000119108UMLSC2888183

What you can answer from here — as of October 24, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Primary Axillary Hyperhidrosis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In